Areva Pharmaceuticals announced it has received its full approval to supply critical drugs need to service the Veterans Administration and the Department of Defense under the Women Owned Minority Business category.

“Areva Pharmaceuticals is pleased to serve the nations veterans and the defense department with critical need drug that has seen an increased demand due to market shortages.  We look forward to serving our healthcare partners with a high level of service commitment just as our veterans serve our nation with their commitment.   This approval further cements Areva’s commitment to alleviating the drug shortage crisis with sterile injectable products produced exclusively in the US and Europe,” says Irene Swaminathan, President & Chairwomen of Areva Pharmaceuticals. “I have worked at the VA as a Staff pharmacist and am proud to serve our veterans with the pharmaceutical products that saves lives. 

About Areva Pharmaceutical

Areva Pharmaceuticals Inc., a US-based healthcare company, specializes in innovative processes to make difficult-to-manufacture specialty and multi source pharmaceutical drugs that are easier to use, less labor intensive, and more streamlined in practice. Areva ensures that its high-quality FDA-approved drugs fulfill a critical unmet medical need and delivers dependable life-saving treatment options when and where they are needed most.

Media Contact

Areva Pharmaceuticals
812-399-1099